Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency.

Baldwin D, Zander J, Munoz C, Raghu P, DeLange-Hudec S, Lee H, Emanuele MA, Glossop V, Smallwood K, Molitch M.

Diabetes Care. 2012 Oct;35(10):1970-4. Epub 2012 Jun 14.

PMID:
22699288
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes.

Smiley D, Umpierrez GE, Hermayer K, Newton C, Jacobs S, Olson DE, Khan A, Rizzo M, Peng L, Reyes D, Cardona S, Fonseca V.

J Diabetes Complications. 2013 Nov-Dec;27(6):637-41. doi: 10.1016/j.jdiacomp.2013.05.007. Epub 2013 Aug 1.

PMID:
23911535
[PubMed - indexed for MEDLINE]
3.

Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).

Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R.

Diabetes Care. 2007 Sep;30(9):2181-6. Epub 2007 May 18.

PMID:
17513708
[PubMed - indexed for MEDLINE]
4.

Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial.

Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, Jacobs S, Rizzo M, Peng L, Reyes D, Pinzon I, Fereira ME, Hunt V, Gore A, Toyoshima MT, Fonseca VA.

Diabetes Care. 2013 Aug;36(8):2169-74. doi: 10.2337/dc12-1988. Epub 2013 Feb 22.

PMID:
23435159
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Glycemic control with insulin glargine plus insulin glulisine versus premixed insulin analogues in real-world practices: a cost-effectiveness study with a randomized pragmatic trial design.

Levin PA, Zhang Q, Mersey JH, Lee FY, Bromberger LA, Bhushan M, Bhushan R.

Clin Ther. 2011 Jul;33(7):841-50. doi: 10.1016/j.clinthera.2011.05.091. Epub 2011 Jun 30.

PMID:
21719107
[PubMed - indexed for MEDLINE]
6.

Glulisine versus human regular insulin in combination with glargine in noncritically ill hospitalized patients with type 2 diabetes: a randomized double-blind study.

Meyer C, Boron A, Plummer E, Voltchenok M, Vedda R.

Diabetes Care. 2010 Dec;33(12):2496-501. doi: 10.2337/dc10-0957. Epub 2010 Aug 30.

PMID:
20805258
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).

Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, Umpierrez D, Newton C, Olson D, Rizzo M.

Diabetes Care. 2011 Feb;34(2):256-61. doi: 10.2337/dc10-1407. Epub 2011 Jan 12.

PMID:
21228246
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Treatment of inpatient hyperglycemia beginning in the emergency department: a randomized trial using insulins aspart and detemir compared with usual care.

Bernard JB, Munoz C, Harper J, Muriello M, Rico E, Baldwin D.

J Hosp Med. 2011 May;6(5):279-84. doi: 10.1002/jhm.866.

PMID:
21661100
[PubMed - indexed for MEDLINE]
9.
10.

Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study.

Owens DR, Luzio SD, Sert-Langeron C, Riddle MC.

Diabetes Obes Metab. 2011 Nov;13(11):1020-7. doi: 10.1111/j.1463-1326.2011.01459.x. Epub 2011 Sep 2.

PMID:
21679291
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.

Hollander P, Cooper J, Bregnhøj J, Pedersen CB.

Clin Ther. 2008 Nov;30(11):1976-87. doi: 10.1016/j.clinthera.2008.11.001.

PMID:
19108786
[PubMed - indexed for MEDLINE]
12.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
[PubMed - indexed for MEDLINE]
13.

Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving preprandial insulin aspart or postprandial insulin glulisine.

Ohta A, Arai K, Nishine A, Sada Y, Kato H, Fukuda H, Asai S, Nagai Y, Katabami T, Tanaka Y.

Endocr J. 2013;60(2):173-7. Epub 2012 Oct 6.

PMID:
23047542
[PubMed - indexed for MEDLINE]
Free Article
14.

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB.

Diabetes Care. 2001 Apr;24(4):631-6.

PMID:
11315821
[PubMed - indexed for MEDLINE]
15.

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

Ann Intern Med. 2005 Oct 18;143(8):559-69.

PMID:
16230722
[PubMed - indexed for MEDLINE]
16.

Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs.

Lankisch MR, Ferlinz KC, Leahy JL, Scherbaum WA; Orals Plus Apidra and LANTUS (OPAL) study group.

Diabetes Obes Metab. 2008 Dec;10(12):1178-85. doi: 10.1111/j.1463-1326.2008.00967.x. Erratum in: Diabetes Obes Metab. 2010 May;12(5):461.

PMID:
19040645
[PubMed - indexed for MEDLINE]
17.

Converting continuous insulin infusion to subcutaneous insulin glargine after cardiac surgery using percentage-based versus weight-based dosing: a pilot trial.

Silinskie KM, Kirshner R, Hite MS.

Ann Pharmacother. 2013 Jan;47(1):20-8. doi: 10.1345/aph.1Q698. Epub 2013 Jan 16.

PMID:
23324510
[PubMed - indexed for MEDLINE]
18.

Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.

Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, Wang C, Kam I, Draznin B.

J Clin Endocrinol Metab. 2012 Sep;97(9):3132-7. doi: 10.1210/jc.2012-1244. Epub 2012 Jun 8.

PMID:
22685233
[PubMed - indexed for MEDLINE]
19.

Insulin glargine dosing before next-day surgery: comparing three strategies.

Rosenblatt SI, Dukatz T, Jahn R, Ramsdell C, Sakharova A, Henry M, Arndt-Mutz M, Miller V, Rogers K, Balasubramaniam M.

J Clin Anesth. 2012 Dec;24(8):610-7. doi: 10.1016/j.jclinane.2012.02.010. Epub 2012 Nov 2.

PMID:
23122972
[PubMed - indexed for MEDLINE]
20.

Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.

Bergenstal RM, Johnson M, Powers MA, Wynne A, Vlajnic A, Hollander P, Rendell M.

Diabetes Care. 2008 Jul;31(7):1305-10. doi: 10.2337/dc07-2137. Epub 2008 Mar 25.

PMID:
18364392
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk